Revolution Medicines price target raised to $64 from $62 at H.C. Wainwright
The Fly

Revolution Medicines price target raised to $64 from $62 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Revolution Medicines (RVMD) to $64 from $62 and keeps a Buy rating on the shares following the Q3 report. The firm says several key clinical data disclosures are anticipated in the coming months.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App